Covered recipient · General Payments record
AMANDA SHAI HOBBS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,360.51
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $632.05 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $254.36 | 18 |
| Regeneron Healthcare Solutions, Inc. | $82.88 | 3 |
| LEO Pharma Inc. | $79.18 | 5 |
| Janssen Biotech, Inc. | $58.71 | 3 |
| Lilly USA, LLC | $38.00 | 2 |
| PFIZER INC. | $37.91 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.13 | 2 |
| GENZYME CORPORATION | $25.03 | 1 |
| UCB, Inc. | $20.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.45 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341424 | CMS |
| ABBVIE INC. | $17.98 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341426 | CMS |
| ABBVIE INC. | $19.65 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341428 | CMS |
| ABBVIE INC. | $24.41 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341430 | CMS |
| ABBVIE INC. | $2.30 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341432 | CMS |
| ABBVIE INC. | $16.55 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341434 | CMS |
| ABBVIE INC. | $7.13 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341436 | CMS |
| ABBVIE INC. | $22.20 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341438 | CMS |
| ABBVIE INC. | $16.06 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341440 | CMS |
| ABBVIE INC. | $21.24 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341442 | CMS |
| ABBVIE INC. | $6.15 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341444 | CMS |
| ABBVIE INC. | $24.26 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341446 | CMS |
| ABBVIE INC. | $10.79 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341448 | CMS |
| ABBVIE INC. | $3.59 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341450 | CMS |
| ABBVIE INC. | $24.53 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341452 | CMS |
| ABBVIE INC. | $17.82 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341454 | CMS |
| ABBVIE INC. | $9.26 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341456 | CMS |
| ABBVIE INC. | $4.99 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107341458 | CMS |
| GENZYME CORPORATION | $25.03 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969811 | CMS |
| Janssen Biotech, Inc. | $20.61 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078557493 | CMS |
| Janssen Biotech, Inc. | $22.25 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078557457 | CMS |
| Janssen Biotech, Inc. | $15.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078557497 | CMS |
| LEO Pharma Inc. | $13.84 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671497 | CMS |
| LEO Pharma Inc. | $13.22 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671499 | CMS |
| LEO Pharma Inc. | $17.36 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671501 | CMS |
| LEO Pharma Inc. | $16.29 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671503 | CMS |
| LEO Pharma Inc. | $18.47 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152671505 | CMS |
| Lilly USA, LLC | $17.54 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135529001 | CMS |
| Lilly USA, LLC | $20.46 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135446249 | CMS |
| Novartis Pharmaceuticals Corporation | $20.20 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086824045 | CMS |
| Novartis Pharmaceuticals Corporation | $14.93 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086824051 | CMS |
| PFIZER INC. | $18.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131877558 | CMS |
| PFIZER INC. | $19.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132120028 | CMS |
| Regeneron Healthcare Solutions, Inc. | $24.84 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114316505 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.61 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114316507 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.43 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114316509 | CMS |
| UCB, Inc. | $20.85 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143235415 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.